AXA SA (CS.PA)

FR0000120628 - Common Stock

32.48  +0.24 (+0.74%)

Fundamental Rating

5

Overall CS gets a fundamental rating of 5 out of 10. We evaluated CS against 32 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS has a correct valuation and a medium growth rate. CS also has an excellent dividend rating. These ratings would make CS suitable for dividend investing!



6

1. Profitability

1.1 Basic Checks

In the past year CS was profitable.
In the past year CS had a positive cash flow from operations.
CS had positive earnings in each of the past 5 years.
In the past 5 years CS always reported a positive cash flow from operatings.

1.2 Ratios

CS has a Return On Assets of 1.09%. This is in the better half of the industry: CS outperforms 64.52% of its industry peers.
Looking at the Return On Equity, with a value of 14.13%, CS is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
The Return On Invested Capital of CS (1.21%) is better than 67.74% of its industry peers.
CS had an Average Return On Invested Capital over the past 3 years of 1.23%. This is in line with the industry average of 2.14%.
Industry RankSector Rank
ROA 1.09%
ROE 14.13%
ROIC 1.21%
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%

1.3 Margins

With a Profit Margin value of 8.23%, CS perfoms like the industry average, outperforming 45.16% of the companies in the same industry.
In the last couple of years the Profit Margin of CS has grown nicely.
CS has a Operating Margin (11.15%) which is in line with its industry peers.
CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.15%
PM (TTM) 8.23%
GM N/A
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CS is destroying value.
The number of shares outstanding for CS has been reduced compared to 1 year ago.
The number of shares outstanding for CS has been reduced compared to 5 years ago.
CS has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.32, we must say that CS is in the distress zone and has some risk of bankruptcy.
CS has a Altman-Z score of 0.32. This is amongst the best in the industry. CS outperforms 93.55% of its industry peers.
The Debt to FCF ratio of CS is 3.74, which is a good value as it means it would take CS, 3.74 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.74, CS is doing good in the industry, outperforming 61.29% of the companies in the same industry.
CS has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
CS has a Debt to Equity ratio of 0.49. This is in the better half of the industry: CS outperforms 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.74
Altman-Z 0.32
ROIC/WACC0.12
WACC10.45%

2.3 Liquidity

A Current Ratio of 0.99 indicates that CS may have some problems paying its short term obligations.
CS's Current ratio of 0.99 is amongst the best of the industry. CS outperforms 87.10% of its industry peers.
CS has a Quick Ratio of 0.99. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS has a Quick ratio of 0.99. This is amongst the best in the industry. CS outperforms 87.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99

4

3. Growth

3.1 Past

CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.00%, which is quite good.
The Earnings Per Share has been growing slightly by 4.77% on average over the past years.
Looking at the last year, CS shows a very negative growth in Revenue. The Revenue has decreased by -15.52% in the last year.
Measured over the past years, CS shows a decrease in Revenue. The Revenue has been decreasing by -4.57% on average per year.
EPS 1Y (TTM)12%
EPS 3Y23.02%
EPS 5Y4.77%
EPS Q2Q%34.3%
Revenue 1Y (TTM)-15.52%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.57%
Sales Q2Q%-18.71%

3.2 Future

The Earnings Per Share is expected to grow by 6.28% on average over the next years.
CS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.14% yearly.
EPS Next Y10.3%
EPS Next 2Y8.65%
EPS Next 3Y8.58%
EPS Next 5Y6.28%
Revenue Next Year-7.52%
Revenue Next 2Y-9.02%
Revenue Next 3Y-4.67%
Revenue Next 5Y3.14%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.55, the valuation of CS can be described as reasonable.
The rest of the industry has a similar Price/Earnings ratio as CS.
CS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.41.
With a Price/Forward Earnings ratio of 8.93, the valuation of CS can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CS is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 20.59. CS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.55
Fwd PE 8.93

4.2 Price Multiples

CS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CS is cheaper than 70.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.05
EV/EBITDA N/A

4.3 Compensation for Growth

CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CS may justify a higher PE ratio.
PEG (NY)1.02
PEG (5Y)2.21
EPS Next 2Y8.65%
EPS Next 3Y8.58%

7

5. Dividend

5.1 Amount

CS has a Yearly Dividend Yield of 6.14%, which is a nice return.
Compared to an average industry Dividend Yield of 5.57, CS pays a bit more dividend than its industry peers.
CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 6.14%

5.2 History

The dividend of CS has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

56.37% of the earnings are spent on dividend by CS. This is a bit on the high side, but may be sustainable.
The dividend of CS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.37%
EPS Next 2Y8.65%
EPS Next 3Y8.58%

AXA SA

EPA:CS (7/26/2024, 7:00:00 PM)

32.48

+0.24 (+0.74%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap72.35B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 6.14%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 10.55
Fwd PE 8.93
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.02
PEG (5Y)2.21
Profitability
Industry RankSector Rank
ROA 1.09%
ROE 14.13%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.15%
PM (TTM) 8.23%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)12%
EPS 3Y23.02%
EPS 5Y
EPS Q2Q%
EPS Next Y10.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.52%
Revenue growth 3Y-7.69%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y